DMD

Business

HHS panel to vote in Nov. on DMD screening for newborns (NASDAQ:SRPT)

Hailshadow An advisory committee of the U.S. Department of Health and Human Services is expected to vote this fall on…

Read More »
Business

Capricor scales up manufacturing capacity for DMD therapy (NASDAQ:CAPR)

Hailshadow/iStock via Getty Images Capricor Therapeutics (NASDAQ:CAPR) said it has scaled up expanded capacity at its new manufacturing facility in…

Read More »
Business

Citi starts Sarepta at buy, likes risk/reward for DMD drug approval (NASDAQ:SRPT)

phive2015 Citi started coverage of Sarepta Therapeutics (NASDAQ:SRPT) with a buy rating, stating that it likes the risk/reward heading into…

Read More »
Back to top button